how many people are on a glp 1 Poll: in 8 Adults Say They've Taken GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease Products - Data Briefs -

Current Research and Clinical Evidence Clinical trials have shown that administering lower doses of semaglutide and tirzepatide not only results in significant weight loss but also minimizes the occurrence of side effects, making it a promising avenue for treatment

I think 80% of the revenues come from consumables but they saw a 40% drop in share price for not really any good reason other than some weakness and the market saw that and pounced, claiming that perhaps the GLP-1s out there are creating some problems for companies that help treat diabetes, right

We have previously characterized several notable benefits through this work, including improved left ventricular performance, increased coronary perfusion to the ischemic myocardial region, diminished apoptotic death of ischemic myocytes, and reduced interstitial and perivascular fibrosis within the perfusion-restricted territory

Insurance coverage and cost for these treatments can vary, as insurance companies dont usually cover weight-loss medications